Purple Biotech Ltd. (PPBT)
NASDAQ
$1.51+$0.0300 (+2.03%) on the dayAs of the close; data may be delayed.
PPBT price, last 12 months
Key stats
- Previous close
- $1.48
- Open
- $1.48
- Day range
- $1.40 – $1.54
- 52-week range
- $1.16 – $14.10
- Volume
- 23.7K
- Avg volume (20 days)
- 4M
- Market cap
- $2.5M
Performance
1W+4.9%
1M−12.7%
3M−10.1%
6M−62.2%
YTD−77.0%
1Y−74.1%
vs S&P 500, 1Y−90.9 pts
Technicals and fundamentals
About Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.
- Listed on
- NASDAQ
- Market cap
- $2.5M